Skip to main content
Terug
Watch Compare

STANDARD BIOTOOLS INC.

Datakwaliteit: 100%
LAB
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 0,91
▼ € 0,03 (-3,00%)
Marktkapitalisatie: 354,46 M
Prijs
€ 0,91
Marktkapitalisatie
354,46 M
Dagbereik
€ 0,89 — € 0,95
52-Weeksbereik
€ 0,87 — € 1,72
Volume
961.056
Openen € 0,95
50D / 200D Gem.
€ 1,11
18,43% below
50D / 200D Gem.
€ 1,28
28,97% below

Quick Summary

Belangrijkste Punten

Revenue declined -10,09% annually over 5 years
Negative free cash flow of -82,65 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 40,99%
Capital efficient — spends only 9,73% of revenue on capex

Groei

Revenue Growth (5Y)
-10,09%
Onder sectorgemiddelde (1,82%)
Revenue (1Y)-51,08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-18,17%
Boven sectorgemiddelde (-53,47%)
ROIC-19,56%
Net Margin-87,77%
Op. Margin-129,20%

Veiligheid

Debt / Equity
N/A
Current Ratio4,38
Interest CoverageN/A

Waardering

PE (TTM)
-4,73
Onder sectorgemiddelde (-1,47)
P/B Ratio0,89
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -4,7 -1,5
P/B 0,9 1,6
ROE % -18,2 -53,5
Net Margin % -87,8 -41,5
Rev Growth 5Y % -10,1 1,8
D/E — 0,3

ETFs Holding This Stock

IRSSX IRSSX
0,01% weight
IRSIX IRSIX
0,01% weight
IIRSX IIRSX
0,01% weight
IRCIX IRCIX
0,01% weight
VVICX VVICX
0,01% weight
IWV logo IWV iShares Russell 3000 ETF
0,00% weight
EBI logo EBI Longview Advantage ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) -51,08% Revenue Growth (3Y) -10,42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -10,09% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 85,33 M Net Income (TTM) -74,90 M
ROE -18,17% ROA -13,66%
Gross Margin 49,86% Operating Margin -129,20%
Net Margin -87,77% Free Cash Flow (TTM) -82,65 M
ROIC -19,56% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4,38
Interest Coverage N/A Asset Turnover 0,16
Working Capital 364,47 M Tangible Book Value 399,66 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,73 Forward P/E N/A
P/B Ratio 0,89 P/S Ratio 4,15
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -23,32%
Market Cap 354,46 M Enterprise Value 225,04 M
Per Share
EPS (Diluted TTM) -0,20 Revenue / Share 0,22
FCF / Share -0,21 OCF / Share -0,19
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 9,73% FCF Conversion 110,35%
SBC-Adj. FCF -124,86 M Growth Momentum -40,99

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 85,33 M 174,43 M 106,34 M 97,95 M 130,58 M
Net Income -74,90 M -138,89 M -74,66 M -190,10 M -59,24 M
EPS (Diluted) -0,20 -0,52 -0,94 -2,43 -0,78
Gross Profit 42,54 M 84,26 M 50,45 M — —
Operating Income -110,25 M -175,24 M -76,60 M -116,21 M -67,46 M
EBITDA — — — — —
R&D Expenses 25,99 M 62,41 M 25,95 M 38,50 M 37,94 M
SG&A Expenses 109,86 M 156,61 M 87,54 M 114,76 M 98,89 M
D&A — 12,30 M 12,67 M 6,22 M —
Interest Expense — — 4,57 M 4,33 M 3,82 M
Income Tax -37,88 M 573.000,0 452.000,0 -2,83 M -4,42 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 567,75 M 612,34 M 323,07 M 390,31 M 275,21 M
Total Liabilities 143,46 M 140,62 M 159,87 M 160,52 M 180,62 M
Shareholders' Equity 424,29 M 471,72 M -148,05 M -81,47 M 94,60 M
Total Debt — 299.000,0 63,51 M — —
Cash & Equivalents 120,86 M 166,73 M 51,70 M 81,31 M 28,45 M
Current Assets 454,26 M 375,88 M 158,22 M 208,82 M 72,07 M
Current Liabilities 108,31 M 65,89 M 109,33 M 43,44 M 49,57 M